Revenue (Quarterly) Chart

View Revenue (Quarterly) for NPRRF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 1.051B
March 31, 2026 1.104B
December 31, 2025 1.103B
September 30, 2025 1.073B
June 30, 2025 1.101B
March 31, 2025 1.085B
December 31, 2024 1.098B
September 30, 2024 1.070B
June 30, 2024 977.95M
March 31, 2024 994.43M
December 31, 2023 1.036B
September 30, 2023 1.005B
June 30, 2023 1.022B
March 31, 2023 1.049B
December 31, 2022 1.032B
September 30, 2022 957.46M
June 30, 2022 985.02M
March 31, 2022 1.078B
December 31, 2021 1.119B
September 30, 2021 1.127B
June 30, 2021 1.079B
March 31, 2021 1.079B
December 31, 2020 1.137B
September 30, 2020 1.068B
June 30, 2020 1.013B
Date Value
March 31, 2020 970.80M
December 31, 2019 1.049B
September 30, 2019 1.052B
June 30, 2019 998.53M
March 31, 2019 954.05M
December 31, 2018 1.002B
September 30, 2018 943.03M
June 30, 2018 945.41M
March 31, 2018 937.49M
December 31, 2017 938.66M
September 30, 2017 850.30M
June 30, 2017 841.77M
March 31, 2017 788.22M
December 31, 2016 845.66M
September 30, 2016 864.21M
June 30, 2016 825.88M
March 31, 2016 803.95M
December 31, 2015 778.43M
September 30, 2015 748.41M
June 30, 2015 725.55M
March 31, 2015 713.14M
December 31, 2014 747.97M
September 30, 2014 760.54M
June 30, 2014 738.73M
March 31, 2014 760.35M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Terumo Corp. 1.957B
Mani, Inc. 52.25M
HOYA Corp. 1.605B
Nakanishi, Inc. 155.29M
Abbott Laboratories 12.59B